AIM
BLUE

Advantage Investment Management’s bluebird bio BLUE Stock Holding History

Advantage Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed -$1K – 1082
2017
Q1 		$1K Sell
1
-198
-99% -$202K ﹤0.01% 929
2016
Q4 		$159K Buy
199
+11
+6% +$8.73K 0.06% 159
2016
Q3 		$165K Sell
188
-24
-11% -$17.4K 0.06% 147
2016
Q2 		$119K Buy
212
+22
+12% +$12.5K 0.06% 202
2016
Q1 		$104K Buy
190
+29
+18% +$17.8K 0.04% 222
2015
Q4 		$134K Buy
161
+7
+5% +$6.99K 0.07% 181
2015
Q3 		$171K Sell
154
-129
-46% -$235K 0.1% 137
2015
Q2 		$617K Buy
283
+15
+6% +$30.6K 0.3% 84
2015
Q1 		$420K Buy
268
+13
+5% +$17.2K 0.24% 97
2014
Q4 		$303K Buy
+255
New +$170K 0.23% 86

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Advantage Investment Management's BLUE Position: Q2 2017 in Review

Advantage Investment Management sold out of bluebird bio (BLUE) in Q2 2017, closing a stake of 1 share — an estimated $1K sold.

Advantage Investment Management first reported a position in BLUE in Q4 2014 and held it in 10 quarters. The position peaked at $617K in Q2 2015. 241 funds tracked by Wall St. Rank hold BLUE as of Q2 2017.

  • Advantage Investment Management reported no remaining bluebird bio position as of Q2 2017 after selling out during the quarter.
  • Advantage Investment Management sold 1 bluebird bio share in Q2 2017, an estimated $1K.
  • Advantage Investment Management first reported a position in bluebird bio in Q4 2014 and held it in 10 quarters.
  • Advantage Investment Management's bluebird bio position peaked at $617K in Q2 2015.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q2 2017.

Based on Advantage Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.